SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Sick Visit — David Hume — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | David Hume |
|---|
| Date of birth | 1711-05-07 |
|---|
| Identifiers | MRN HR-EN012-SYN-TD; SSN (made up) 000-12-3049 |
|---|
| Document date | 1775-09-08 |
|---|
| Author | Fiona Gallacher, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Chief Complaint
Runny nose, sore throat, and cough for three days during chemotherapy. [S]
History of Present Illness
Mr. Hume is a 64-year-old man with stage IIIB sigmoid colon cancer, resected in June, who is on day 9 of his third 21-day cycle of adjuvant CAPOX (oxaliplatin given on day 1, capecitabine on days 1 to 14). Three days ago he developed a runny nose and scratchy throat, followed by a dry cough. He called the oncology triage line this morning, as his chemotherapy plan instructs, and was asked to be seen in primary care today with a blood count. His home temperatures have been 37.1 to 37.4 °C, checked twice daily, and he has not taken acetaminophen, so no fever has been masked. A home COVID-19 antigen test yesterday was negative. He is eating and drinking normally, has had two soft stools a day without diarrhea, no mouth sores, and no redness or peeling of his palms or soles. The cold tingling in his fingers after each oxaliplatin dose settles within five days, as before. A friend who visited last week had a cold. [S]
| Element | Detail |
|---|
| Onset | Three days ago |
| Location | Nose, throat, and chest |
| Duration | Three days |
| Character | Clear nasal discharge, scratchy throat, dry cough |
| Severity | Mild; sleeping normally |
| Timing | Day 9 of the third CAPOX cycle |
| Context | Exposure to a visitor with a cold; on capecitabine |
| Modifying factors | Warm drinks help; no medicines taken |
| Associated signs and symptoms | No fever, chills, breathlessness, chest pain, diarrhea, mouth sores, or hand-foot symptoms |
Review of Systems
| System | Result | Finding |
|---|
| Constitutional | Negative | No fever above 37.4 °C, chills, or rigors; usual chemotherapy tiredness |
| Ears, nose, mouth, and throat | Positive | Clear rhinorrhea and sore throat; no mouth ulcers, ear pain, or facial pain |
| Respiratory | Positive | Dry cough; no breathlessness, wheeze, sputum, or hemoptysis |
| Cardiovascular | Negative | No chest pain or palpitations |
| Gastrointestinal | Negative | No nausea, vomiting, diarrhea, or abdominal pain |
| Genitourinary | Negative | No dysuria or frequency |
| Integumentary | Negative | No palmar or plantar redness, peeling, or blistering |
| Neurological | Positive | Brief cold-triggered tingling of the fingers after oxaliplatin, resolving between doses; no numbness at rest |
8 systems reviewed. [S]
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Ferric carboxymaltose 750 mg intravenous infusion, two doses one week apart | 750 mg IV once a week for two doses | Intravenous route | 1775-06-01 to 1775-06-08 | completed | S |
| Capecitabine 500 mg oral tablet, four tablets (1749 mg, 1000 mg/m²) by mouth twice daily on days 1 to 14 of each 21-day cycle, four cycles | Four tablets twice daily on days 1 to 14 of each 21-day cycle | Oral route | 1775-07-20 to 1775-10-04 | completed | S |
| Oxaliplatin 130 mg/m² (260 mg) intravenous infusion on day 1 of each 21-day cycle, four cycles | 260 mg IV on day 1 every 21 days | Intravenous route | 1775-07-20 to 1775-09-21 | completed | S |
| Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours as needed for nausea during chemotherapy | One tablet every 8 hours as needed for nausea | Oral route | 1775-07-20 to 1775-10-04 | completed | S |
| Loperamide 2 mg oral capsule, two capsules after the first loose stool, then one after each loose stool, no more than eight a day | As needed for diarrhea on capecitabine | Oral route | 1775-07-20 to 1775-10-04 | completed | S |
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 1775-09-08 | Body height | 178 | cm | S |
| 1775-09-08 | Body weight | 81.6 | kg | S |
| 1775-09-08 | Body mass index (BMI) [Ratio] | 25.8 | kg/m2 | S |
| 1775-09-08 | Systolic blood pressure | 118 | mm[Hg] | S |
| 1775-09-08 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1775-09-08 | Heart rate | 84 | /min | S |
| 1775-09-08 | Respiratory rate | 16 | /min | S |
| 1775-09-08 | Body temperature | 37.3 | Cel | S |
| 1775-09-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 1775-09-08 | Leukocytes [#/volume] in Blood by Automated count | 4.6 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 1775-09-08 | Neutrophils [#/volume] in Blood by Automated count | 2.4 | 10*3/uL | 1.5-7.7 10*3/uL | Normal | S |
| 1775-09-08 | Hemoglobin [Mass/volume] in Blood | 12.1 | g/dL | 13.2-16.6 g/dL | Low | S |
| 1775-09-08 | Platelets [#/volume] in Blood by Automated count | 156 | 10*3/uL | 150-400 10*3/uL | Normal | S |
Physical Exam
Vital signs recorded on 1775-09-08; see the Vital Signs section. [S]
| System | Finding |
|---|
| General | Well-appearing, comfortable, speaking easily |
| Ears, nose, and throat | Nasal mucosa red with clear discharge; pharynx mildly red without exudate; no oral mucositis |
| Neck | No tender or enlarged nodes |
| Respiratory | Unlabored; clear to auscultation; no crackles or wheeze |
| Cardiovascular | Regular rhythm, heart rate 84 |
| Abdomen | Laparoscopic port scars healed; soft and non-tender |
| Skin | Palms and soles normal |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Adenocarcinoma of the sigmoid colon, suspected at presentation and confirmed by colonoscopic biopsy; synthetic modern diagnosis linked to the documented 1775 bowel disorder and its retrospective interpretation as colon cancer | active | confirmed |
C18.7 | S — Synthetic diagnosis confirmed by biopsy and resection in the modern episode; the historical diagnosis remains a retrospective interpretation (R). |
| Iron deficiency anemia from chronic blood loss from the colon tumor | active | confirmed |
D50.0 | S — Synthetic finding echoing the documented 'hemorrhage in the upper part of the intestines'; no blood count from his lifetime exists. |
| Hemangioma of the liver, 9 mm, segment VI; incidental finding characterized by MRI, not a metastasis | active | confirmed |
D18.03 | S — Synthetic incidental finding; it addresses, and does not confirm, the unverified suggestion of liver spread. |
| Acute viral upper respiratory infection during adjuvant chemotherapy, without fever or neutropenia; resolved | resolved | confirmed |
J06.9 | S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness. |
Assessment and Plan
- Acute viral upper respiratory infection, without fever or neutropenia (J06.9). Afebrile at 37.3 °C with a clear chest and normal oxygen saturation. White cell count 4.6 and absolute neutrophil count 2.4 exclude neutropenia, so this is not febrile neutropenia and antibiotics are not indicated. [S]
- Supportive care: fluids, rest, saline nasal rinse, and honey for the cough.
- Check his temperature before any acetaminophen dose so that a fever is not masked.
- Repeat the home COVID-19 antigen test in 48 hours; call the same day if it is positive, because antiviral treatment would be considered after a drug-interaction check.
- Call the oncology 24-hour line at once, and go to the emergency department if told to, for a temperature of 38.0 °C or higher, chills, or breathlessness.
- Stage IIIB sigmoid colon cancer on adjuvant CAPOX, cycle 3 (C18.7). No chemotherapy toxicity needing a dose change: no diarrhea, mucositis, or hand-foot syndrome, and the blood count allows treatment. [S]
- Continue capecitabine to day 14 as prescribed; results and plan sent to the oncology team today, who agreed.
- Stop capecitabine and call oncology if he develops four or more extra stools a day, mouth sores that stop him eating, or painful red palms or soles.
Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Colon Cancer, Version 4.2025 (2025); Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update (2018); Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention (2016)
Follow-up: Oncology team updated today. Nurse telephone check in two days. Cycle 4 as scheduled if well. Next scheduled visit 1775-10-19: review two weeks after completing adjuvant CAPOX and start of survivorship surveillance. [S]